Vivani Medical, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Vivani Medical, Inc. (VANI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $62.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-13
- Vivani Medical, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $28.00K, a 47.17% decline year-over-year.
- Vivani Medical, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $34.00K, a 44.26% decline year-over-year.
- Vivani Medical, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $116.00K, a 93.33% increase year-over-year.
- Vivani Medical, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $39.00K, a 36.07% decline year-over-year.
- Vivani Medical, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $269.00K, a 2.54% decline from fiscal 2024.
- Vivani Medical, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $276.00K, a 69.47% decline from fiscal 2023.
- Vivani Medical, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $904.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $62.00K 10-Q · filed 2026-08-13 | $178.00K derived: sum of 3 quarters · filed 2026-08-13 | $217.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $34.00K 10-Q · filed 2026-05-13 | $150.00K derived: sum of 2 quarters · filed 2026-05-13 | $189.00K derived: sum of 3 quarters · filed 2026-05-13 | $242.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $155.00K derived: sum of 2 quarters · filed 2026-03-26 | $208.00K derived: sum of 3 quarters · filed 2026-08-13 | $269.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $92.00K derived: sum of 2 quarters · filed 2026-08-13 | $153.00K 10-Q · filed 2025-11-13 | $213.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $114.00K 10-Q · filed 2026-08-13 | $174.00K derived: sum of 3 quarters · filed 2026-08-13 | $235.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $61.00K 10-Q · filed 2026-05-13 | $121.00K derived: sum of 2 quarters · filed 2026-05-13 | $182.00K derived: sum of 3 quarters · filed 2026-05-13 | $255.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $121.00K derived: sum of 2 quarters · filed 2026-03-26 | $194.00K derived: sum of 3 quarters · filed 2026-03-26 | $276.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $134.00K derived: sum of 2 quarters · filed 2025-11-13 | $216.00K 10-Q · filed 2025-11-13 | $291.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $155.00K 10-Q · filed 2025-08-13 | $230.00K derived: sum of 3 quarters · filed 2025-08-13 | $931.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $82.00K 10-Q · filed 2025-05-13 | $157.00K derived: sum of 2 quarters · filed 2025-05-13 | $858.00K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2023-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $776.00K derived: sum of 2 quarters · filed 2025-03-31 | $904.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $829.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $128.00K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |